| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/22/2008 | CA2669345A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 05/21/2008 | EP1923466A2 Vectors encoding recombinant AAV genomes |
| 05/21/2008 | EP1923071A1 Equine herpesvirus vaccine |
| 05/21/2008 | EP1923070A1 Vaccine for vaccinating feline against influenza virus |
| 05/21/2008 | EP1922085A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
| 05/21/2008 | EP1467753B1 Recombinant herpesvirus of turkeys and use thereof |
| 05/21/2008 | EP1326963B1 Microorganisms rendered non-pathogenic |
| 05/21/2008 | EP1227837B1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/21/2008 | EP0904395B1 Herpes simplex virus strains |
| 05/21/2008 | EP0752887B1 Immunodeficiency recombinant poxvirus |
| 05/21/2008 | CN101182494A Gene ó¸ type new castle disease virus weakening strain A-NDV-ó¸ and construction method thereof |
| 05/21/2008 | CN100389193C Method for safe continuous enclosed cell culture, virus production/ inactivation |
| 05/20/2008 | US7374875 Peptides having affinity for the gp120 viral protein and use thereof |
| 05/20/2008 | US7374874 Bacteriophages that infect Bacillus bacteria (Anthrax) |
| 05/20/2008 | US7374870 Systems and methods for removing viral agents from blood |
| 05/20/2008 | US7374752 Reovirus for the treatment of cellular proliferative disorders |
| 05/20/2008 | CA2283231C Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 05/15/2008 | WO2008057550A2 Stabilization of vaccines by lyophilization |
| 05/15/2008 | US20080113335 Novel Hiv-Based Recombinant Viral Clones and Use Thereof in Analytical Methods |
| 05/15/2008 | US20080112973 Chimeric papillomavirus-like particles |
| 05/15/2008 | US20080112969 Comprising a US2 gene having inserted a foreign DNA sequence capable of being expressed in a host cell that has been infected by the recombinant avian herpes virus; bird vaccines for Marek's disease, Newcastle disease and the infectious laryngotracheitis virus; veterinary medicine; genetic vectors |
| 05/15/2008 | CA2668834A1 Stabilization of vaccines by lyophilization |
| 05/14/2008 | EP1920783A1 Recombinant RSV virus expression systems and vaccines |
| 05/14/2008 | EP1920049A1 Virus-interacting layered phyllosilicates and methods of inactivating viruses |
| 05/14/2008 | EP1220948B1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/14/2008 | CN201058157Y Disposable filter for blanching blood virus |
| 05/14/2008 | CN101180392A Methods for recovering microorganism and nucleic acid using fine particle and kit to be used for the methods |
| 05/14/2008 | CN101180082A Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of SIV-PEDF vector |
| 05/14/2008 | CN100387716C Preparation of KTV series products for inhibiting tumor cell growth and use |
| 05/14/2008 | CN100387710C Therapy for primary and metastatic cancers |
| 05/13/2008 | US7371846 Chemokine coreceptor fusion for use prevention and treatment of viral infection; immunotherapy |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371572 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection |
| 05/13/2008 | US7371570 replication-competent; comprising an epstein-barr virus (EBV)-specific transcriptional regulatory element (TRE); genetic engineering |
| 05/13/2008 | US7371391 Papilloma virus capsomere vaccine formulations and methods of use |
| 05/13/2008 | CA2360833C Reovirus for the treatment of cellular proliferative disorders |
| 05/13/2008 | CA2166291C Htlv-iinra compositions and assays for detecting htlv infection |
| 05/08/2008 | WO2008054481A2 Improved inactivated influenza virus compositions |
| 05/08/2008 | WO2008054030A1 IgG-BINDING PEPTIDE |
| 05/08/2008 | WO2007122517A3 Influenza h5 pseudotyped lentiviruses and uses thereof |
| 05/08/2008 | US20080108789 Biological scaffold composed of an avian pancreatic polypeptide comprised of leucine zipper domain for use in designing modulators for prevention and treatment of cell proliferative disorders |
| 05/08/2008 | US20080108129 Using replication defective vectors to generate tumor specific immunoglobulins; tissue targeted therapy; immunotherapy |
| 05/08/2008 | US20080108128 Resonance Energy Transfer Assay System for Multi-Component Detection |
| 05/08/2008 | US20080108107 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 05/08/2008 | US20080108053 Compositions and methods for purifying and crystallizing molecules of interest |
| 05/08/2008 | US20080108051 Using immunodiagnostics to detect RNA virus infection |
| 05/08/2008 | US20080107693 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis B virus sequences |
| 05/08/2008 | US20080107688 Virulent systemic feline calicivirus |
| 05/08/2008 | US20080107685 Serotypes produced by site directed mutagenesis; immunogens; vaccines |
| 05/08/2008 | US20080107683 Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof |
| 05/07/2008 | EP1918380A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 05/07/2008 | EP1917351A2 Attenuated reovirus |
| 05/07/2008 | EP1340813B1 Process for producing viral rna polymerase |
| 05/07/2008 | EP0764213B1 Vectors encoding recombinant aav genomes |
| 05/07/2008 | CN101173282A Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 05/07/2008 | CN101173252A Armoured RNA and method for producing the same |
| 05/07/2008 | CN101173251A Method for rapidly removing three viruses of lily |
| 05/07/2008 | CN101172999A Insect-resistant transgenic plants and methods for improving delta-endotoxin activity against insects |
| 05/06/2008 | US7368557 Comprises DNA from RNA virus which codes for RNA polymerase and nonstructural protein in bacterial artificial chromosome; virions; gene therapy |
| 05/06/2008 | US7368286 Using trangenic cells overexpressing human estrogen receptor gene as model for identifying modulators for treating diabetes, obesity and insulin resistance |
| 05/06/2008 | US7368116 Method of enhancing a targeted immune response against tumors |
| 05/06/2008 | CA2142746C Rev-independent hiv expression and replication |
| 05/02/2008 | WO2008051698A2 A serum-free virus propagation platform for a virus vaccine candidate |
| 05/01/2008 | US20080104732 Methods and means for obtaining modified phenotypes |
| 05/01/2008 | US20080104718 Transgenic Non-Human Animal Models of Ischemia-Reperfusion Injury and Uses Thereof |
| 05/01/2008 | US20080102524 Freeze-Dried Composition of Inactivated Virus Envelope with Membrane Fusion Activity |
| 05/01/2008 | US20080102508 Formulation of adenovirus for gene therapy |
| 05/01/2008 | US20080102507 Nutrient broth comprising chicken embryo particles for production of viral antigen; vaccine development |
| 05/01/2008 | US20080102446 Using viral suface proteins as tools in detection and quantification of viruses in biolgical samples |
| 05/01/2008 | US20080102445 Using viral suface proteins as tools in detection and quantification of viruses in biolgical samples |
| 04/30/2008 | EP1916304A2 Antigenic polypeptides associated with multiple sclerosis and uses |
| 04/30/2008 | EP1916298A1 Method for production of antibody |
| 04/30/2008 | EP1916258A2 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs |
| 04/30/2008 | EP1212417B1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 04/30/2008 | EP1034254B1 Uses of immortalized, homozygous stat1-deficient mammalian cell lines |
| 04/30/2008 | CN101168743A Recombination baculoviral and its preparation method and application |
| 04/30/2008 | CN101168742A Oncolytic virus and its preparing method |
| 04/30/2008 | CN100384990C Method for constructing non-virulent strain of infectious bursal disease virus |
| 04/30/2008 | CN100384989C Collecting method for insect virus breed |
| 04/30/2008 | CN100384988C Chicken astrovirus type 2 |
| 04/29/2008 | US7364893 infectious laryngotracheitis viral genome which contains a deletion in the glycoprotein gG gene, US2 gene, UL47-like gene. ORF4 gene; polypeptide is derived from infectious bronchitis virus, Newcastle disease virus, infectious bursal disease virus, and Marek's disease virus; vaccines |
| 04/29/2008 | CA2273074C In ovo vaccination against newcastle disease |
| 04/24/2008 | WO2008016994A3 Harnessing wnt signaling to restrict hiv replication |
| 04/24/2008 | WO2007072049A3 Particle binding |
| 04/24/2008 | US20080096959 Durable Biocides and Disinfectants |
| 04/24/2008 | US20080096813 Generation of potent dominant negative transcriptional inhibitors |
| 04/24/2008 | US20080096769 Phage displayed trp cage ligands |
| 04/24/2008 | US20080096278 Using aldehyde dehydrogenase as tool to activate the rice tungro bacilliform virus (RTBV) promoter in vivo; enhancing heterologus gene expression |
| 04/24/2008 | US20080096264 Attenuated parainfluenza virus (PIV) vaccines |
| 04/24/2008 | US20080096263 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus |
| 04/24/2008 | US20080096187 Molecular Scaffolds for HIV-1 Epitopes |
| 04/24/2008 | US20080095833 Immunogens; expression cassettes; gag genes; tat proteins; DNA vaccines; vpr genes; rev genes; envelope genes; antigen presenting cells; liposomes |
| 04/24/2008 | US20080095797 Marek's disease virus having a mutation in one or both Meq genes thereof such that the virus is non-pathogenic; vaccines; for prevention or treatment of Marek's disease in poultry |
| 04/24/2008 | US20080095796 IBD virus TY2 strain or a passage strain of said viral strain allows for production of a vaccine that is efficacious to IBD variant viral strains that may have new properties not protectable by the conventional vaccines |
| 04/24/2008 | US20080095744 Using conditionally replicative herpes viral vector comprising cytokine sequences to transform cells and activate immune response from CD4, CD8 and natural killer cells towards aberrently proliferating cells; immunotherapy |
| 04/24/2008 | CA2666357A1 Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors |
| 04/23/2008 | EP1434858B1 Method for the amplification of a poxvirus under serum free conditions |
| 04/23/2008 | EP1372712B1 Equine herpesvirus vaccine |
| 04/23/2008 | EP1214398B1 Chimeric virus-like particles or chimeric capsomers from bpv |
| 04/23/2008 | EP1032695B1 Adenovirus vectors and method for reducing homologous recombination phenomena |